Predict your next investment

HEALTHCARE | Biotechnology
transomic.com

See what CB Insights has to offer

Stage

Unattributed - II | Alive

Total Raised

$1.66M

Last Raised

$1.12M | 6 yrs ago

Revenue

$0000 

About transOMIC Technologies

transOMIC technologies is a biotechnology company focused on providing the life science research market with technologies and research tools to accelerate the quest towards elucidating the complexity of life and human disease. The company aims to provide next-generation research tools to help unravel genetic complexity and understand disease development. This mission, coupled with a deep understanding of the tools that life science researchers need, drives our focus to be a research partner; delivering technologies in a cost-effective and technically supported manner to enable discovery across the genome.

transOMIC Technologies Headquarter Location

601 Genome Way Suite 1222

Huntsville, Alabama, 35806,

United States

256-328-9513

Latest transOMIC Technologies News

Transomic CRISPR library to be implemented at the Victorian Centre for Functional Genomics

May 16, 2019

News provided by Share this article HUNSTVILLE, Ala., May 16, 2019 /PRNewswire/ -- Transomic Technologies, located on the campus of the HudsonAlpha Institute for Biotechnology, has announced that their CRISPR whole genome arrayed library has been purchased by the Victorian Centre for Functional Genomics (VCFG) at the Peter MacCallum Cancer Center in Melbourne, Australia. Through this arrangement, Transomic Technologies will provide the Peter MacCallum Cancer Center (Peter Mac) research community with access to the latest in genomic tools. Use of Transomic's CRISPR library will be overseen by Associate Professor Kaylene Simpson, head of the VCFG, which is an internationally recognized high throughput screening facility with a long history in enabling researchers to access and screen using gene knockdown and knockout technologies. "The VCFG has established both arrayed, synthetic- and pooled lentiviral-screens and sees the purchase of the transEDIT library as a high value resource to drive target validation, create pooled screening options and position researchers to generate dual gene targeting constructs," says Associate Professor Simpson. Blake Simmons, CEO of Transomic Technologies, says: "Our transEDIT-dual CRISPR arrayed library is built around the incredible power of the CRISPR-Cas9 gene-editing technology." "This is one of the many tools we offer life science researchers enabling them to make discoveries that ultimately lead to a healthier generation." These CRISPR genome-editing tools and other gene modulation tools can be purchased through Transomic Technologies at  www.transomic.com . About Transomic: Transomic Technologies provides innovative tools and strategies for life science research to help unravel genetic complexity and understand disease development. This mission, coupled with a good understanding of the tools that life science researchers need, drives our focus to be a research partner; delivering technologies in a cost-effective and technically supported manner to enable discovery across the genome. We have an extensive offering of gene-based products to enable research scientists to perform genome editing, gene knockdown, and gene over-expression studies. These types of studies produce insights into gene function which ultimately provide biological understanding of disease and possibilities for therapies. Our leading-edge products are developed through ongoing collaborations with academic thought leaders. Contact: Blake Simmons, 1-256-327-9513, blake@transomic.com SOURCE Transomic Technologies

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing transOMIC Technologies

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

transOMIC Technologies is included in 1 Expert Collection, including Biopharmaceuticals.

B

Biopharmaceuticals

5,732 items

Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.

transOMIC Technologies Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

transOMIC Technologies Rank

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.